非药物干预方式改善慢性病共病相关机制研究进展

doi:10.12114/j.issn.1007-9572.2021.01.102

摘要/Abstract

摘要： 在目前药物治疗负担过于繁重的背景下，非药物干预亦能作为一种重要的辅助或主导的治疗方式参与慢性病尤其共病的管理过程，其治疗潜力如今越来越得到重视，尤其在慢性病中。非药物干预的作用益处已经被广泛认识，而对其具体的作用机制仍未建立系统的认知，因此，本文从运动、饮食及心理等层面总结了目前非药物干预方式改善慢性病的作用机制，通过调节炎症-免疫反应、应激反应、葡萄糖及脂质代谢、基因表达及肠道菌群，各个通路各自或交互作用影响疾病进程，帮助临床医生更全面的认识慢性病共存的复杂机制，而非药物干预作为该复杂网络的统一阻断方法，成为有巨大潜力的慢性病共病治疗管理手段。

关键词: 非药物干预, 慢性病共病, 作用机制, 综述

Abstract: As an important adjuvant therapy or primary treatment for single or multiple chronic conditions，the efficacy of non-pharmacological interventions has been widely recognized，and the potential of them has been valued increasingly，especially when pharmacological interventions constitute a considerable economic burden，but there is a lack of systematic understanding of the possible mechanism of action of non-pharmacological interventions. Considering this，we reviewed mechanisms of actions of current non-pharmacological interventions （involving exercise，diet and psychology） for chronic diseases，which affect the disease development through regulating inflammation-immune responses，and stress responses，modulating glucose and lipid metabolism，gene expression and intestinal microbiota，via each pathway individually or interactively. This review will help to enhance the understanding of the complex pathogenesis of multimorbidity，and the great potential of non-pharmacological interventions against the pathogenesis.

Key words: Non-pharmacological intervention, Multiple chronic conditions, Mechanisms, Review

赵敏君,李双庆. 非药物干预方式改善慢性病共病相关机制研究进展[J]. 中国全科医学, 2021, 24(26): 3369-3376. DOI: 10.12114/j.issn.1007-9572.2021.01.102.
ZHAO Minjun,LI Shuangqing. Latest Advances in Mechanisms of Non-pharmacological Interventions to Improve Multiple Chronic Conditions　[J]. Chinese General Practice, 2021, 24(26): 3369-3376. DOI: 10.12114/j.issn.1007-9572.2021.01.102.

参考文献

［1］MATHERS C D，LONCAR D. Projections of global mortality and burden of disease from 2002 to 2030［J］. PLoS Med，2006，3（11）：e442. DOI：10.1371/journal.pmed.0030442.
［2］VETRANO D L，CALDERóN-LARRA?AGA A，MARENGONI A，et al. An international perspective on chronic multimorbidity：approaching the elephant in the room［J］. J Gerontol A Biol Sci Med Sci，2018，73（10）：1350-1356. DOI：10.1093/ andom/glx178.
［3］DUGRAVOT A，FAYOSSE A，DUMURGIER J，et al. Social inequalities in multimorbidity，frailty，disability，and transitions to mortality：a 24-year follow-up of the Whitehall II cohort study［J］. Lancet Public Health，2020，5（1）：e42-50. DOI：10.1016/S2468-2667（19）30226-9.
［4］FU J M，LIU Y P，ZHANG L，et al. Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension［J］. J Am Heart Assoc，2020，9（19）：e016804. DOI：10.1161/JAHA.120.016804.
［5］LIANOV L，JOHNSON M. Physician competencies for prescribing lifestyle medicine［J］. JAMA，2010，304（2）：202-203. DOI：10.1001/jama.2010.903.
［6］MOKDAD A H，MARKS J S，STROUP D F，et al. Actual causes of death in the United States，2000［J］. JAMA，2004，291（10）：1238-1245. DOI：10.1001/jama.291.10.1238.
［7］BARNES P J.Mechanisms of development of multimorbidity in the elderly［J］. Eur Respir J，2015，45（3）：790-806. DOI：10.1183/09031936.00229714.
［8］FRIEDMAN E M，MROCZEK D K，CHRIST S L. Multimorbidity，
inflammation，and disability：a longitudinal mediational analysis［J］. Ther Adv Chronic Dis，2019，10：2040622318806848. DOI：10.1177/2040622318806848.
［9］JONES S A，JENKINS B J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer［J］. Nat Rev Immunol，2018，18（12）：773-789. DOI：10.1038/s41577-018-0066-7.
［10］STURMBERG J P，BENNETT J M，MARTIN C M，et al. ‘Multimorbidity’ as the manifestation of network disturbances［J］. J Eval Clin Pract，2017，23（1）：199-208. DOI：10.1111/jep.12587.
［11］DHALWANI N N，O'DONOVAN G，ZACCARDI F，et al. Long terms trends of multimorbidity and association with physical activity in older English population［J］. Int J Behav Nutr Phys Act，2016，13：8. DOI：10.1186/s12966-016-0330-9.
［12］VANCAMPFORT D，KOYANAGI A，WARD P B，et al. Chronic physical conditions，multimorbidity and physical activity across 46 low- and middle-income countries［J］. Int J Behav Nutr Phys Act，2017，14（1）：6. DOI：10.1186/s12966-017-0463-5.
［13］HOPPS E，CANINO B，CAIMI G. Effects of exercise on inflammation markers in type 2 diabetic subjects［J］. Acta Diabetol，2011，48（3）：183-189. DOI：10.1007/s00592-011-0278-9.
［14］PEDERSEN B K. The anti-inflammatory effect of exercise：its role in diabetes and cardiovascular disease control［J］. Essays Biochem，2006，42：105-117. DOI：10.1042/bse0420105.
［15］HOJMAN P，GEHL J，CHRISTENSEN J F，et al. Molecular mechanisms linking exercise to cancer prevention and treatment［J］. Cell Metab，2018，27（1）：10-21. DOI：10.1016/j.cmet.2017.09.015.
［16］HAWLEY J A，HARGREAVES M，JOYNER M J，et al. Integrative biology of exercise［J］. Cell，2014，159（4）：738-749. DOI：10.1016/j.cell.2014.10.029.
［17］FERREIRA R C，FREITAG D F，CUTLER A J，et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases［J］. PloS Genet，2013，9（4）：e1003444. DOI：10.1371/journal.pgen.1003444.
［18］LI Y，FENG J，SONG S，et al. Gp130 controls cardiomyocyte proliferation and heart regeneration［J］. Circulation，2020，142（10）：967-982. DOI：10.1161/CIRCULATIONAHA.119.044484.
［19］GLEESON M，BISHOP N C，STENSEL D J，et al. The anti-inflammatory effects of exercise：mechanisms and implications for the prevention and treatment of disease［J］. Nat Rev Immunol，2011，11（9）：607-615. DOI：10.1038/nri3041.
［20］WALSH N P，GLEESON M，SHEPHARD R J，et al. Position statement.Part one：Immune function and exercise［J］. Exerc Immunol Rev，2011，17：6-63.
［21］WEDELL-NEERGAARD A S，LANG LEHRSKOV L，CHRISTENSEN R H，et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling：a randomized controlled trial［J］. Cell Metab，2019，29（4）：844-855.e3. DOI：10.1016/j.cmet.2018.12.007.
［22］FULLER K N Z，SUMMERS C M，VALENTINE R J. Effect of a single bout of aerobic exercise on high-fat meal-induced inflammation［J］. Metabolism，2017，71：144-152. DOI：10.1016/j.metabol.2017.03.001.
［23］WEINHOLD M，SHIMABUKURO-VORNHAGEN A，FRANKE A，et al. Physical exercise modulates the homeostasis of human regulatory T cells［J］. J Allergy Clin Immunol，2016，137（5）：1607-1610.e8. DOI：10.1016/j.jaci.2015.10.035.
［24］DESDíN-MICó G，SOTO-HEREDERO G，ARANDA J F，et al.
T cells with dysfunctional mitochondria induce multimorbidity and premature senescence［J］. Science，2020，368（6497）：1371-1376. DOI：10.1126/science.aax0860.
［25］HOOD D A，MEMME J M，OLIVEIRA A N，et al. Maintenance of skeletal muscle mitochondria in health，exercise，and aging［J］. Annu Rev Physiol，2019，81：19-41. DOI：10.1146/annurev-physiol-020518-114310.
［26］ZHENG J J，PENA CALDERIN E，HILL B G，et al. Exercise promotes resolution of acute inflammation by catecholamine-mediated stimulation of andomize D1 biosynthesis［J］. J Immunol，2019，203（11）：3013-3022. DOI：10.4049/jimmunol.1900144.
［27］KRüGER K，AGNISCHOCK S，LECHTERMANN A，et al. Intensive resistance exercise induces lymphocyte apoptosis via cortisol and glucocorticoid receptor-dependent pathways［J］. J Appl Physiol（1985），2011，110（5）：1226-1232. DOI：10.1152/japplphysiol.01295.2010.
［28］DUGGAL N A，POLLOCK R D，LAZARUS N R，et al. Major features of immunesenescence，including reduced thymic output，are ameliorated by high levels of physical activity in adulthood［J］. Aging Cell，2018，17（2）：e12750. DOI：10.1111/acel.12750.
［29］DUGGAL N A，NIEMIRO G，HARRIDGE S D R，et al. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity？［J］. Nat Rev Immunol，2019，19（9）：563-572. DOI：10.1038/s41577-019-0177-9.
［30］ROSSMAN M J，KAPLON R E，HILL S D，et al. Endothelial cell senescence with aging in healthy humans：prevention by habitual exercise and relation to vascular endothelial function［J］. Am J Physiol Heart Circ Physiol，2017，313（5）：H890-895. DOI：10.1152/ajpheart.00416.2017.
［31］FIUZA-LUCES C，SANTOS-LOZANO A，JOYNER M，et al. Exercise benefits in cardiovascular disease：beyond attenuation of traditional risk factors［J］. Nat Rev Cardiol，2018，15（12）：731-743. DOI：10.1038/s41569-018-0065-1.
［32］HOU Z X，QIN X H，HU Y Y，et al. Longterm exercise-derived exosomal miR-342-5p：a novel exerkine for cardioprotection［J］. Circ Res，2019，124（9）：1386-1400. DOI：10.1161/CIRCRESAHA.118.314635.
［33］ZHANG Y，WAN J Y，LIU S Q，et al. Exercise induced improvements in insulin sensitivity are concurrent with reduced NFE2/miR-432-5p and increased FAM3A［J］. Life Sci，2018，207：23-29. DOI：10.1016/j.lfs.2018.05. 040.
［34］DENHAM J，MARQUES F Z，O'BRIEN B J，et al. Exercise：putting action into our epigenome［J］. Sports Med，2014，44（2）：189-209. DOI：10.1007/s40279-013-0114-1.
［35］BROWN W M. Exercise-associated DNA methylation change in skeletal muscle and the importance of imprinted genes：a bioinformatics meta-analysis［J］. Br J Sports Med，2015，49（24）：1567-1578. DOI：10.1136/bjsports-2014-094073.
［36］JOSEPH J S，AYELESO A O，MUKWEVHO E. Exercise increases hyper-acetylation of histones on the Cis-element of NRF-1 binding to the Mef2a promoter：implications on type 2 diabetes［J］. Biochem Biophys Res Commun，2017，486（1）：83-87. DOI：10.1016/j.bbrc.2017.03.002.
［37］LIGIBEL J A，DILLON D，GIOBBIE-HURDER A，et al. Impact of a pre-operative exercise intervention on breast cancer proliferation and gene expression：results from the pre-operative health and body（PreHAB） study［J］. Clin Cancer Res，2019，25（17）：5398-5406. DOI：10.1158/1078-0432.CCR-18-3143.
［38］DEKKER J，BUURMAN B M，VAN DER LEEDEN M. Exercise in people with comorbidity or multimorbidity［J］. Health Psychol，2019，38（9）：822-830. DOI：10.1037/hea0000750.
［39］RAUTIAINEN S，MANSON J E，LICHTENSTEIN A H，et al. Dietary supplements and disease prevention-a global overview［J］. Nat Rev Endocrinol，2016，12（7）：407-420. DOI：10.1038/nrendo.2016.54.
［40］GBD DIET COLLABORATORS. Health effects of dietary risks in 195 countries，1990—2017：a systematic analysis for the Global Burden of Disease Study 2017［J］. Lancet，2019，393（10184）：1958-1972. DOI：10.1016/S0140-6736（19）30041-8.
［41］ESTRUCH R，ROS E，SALAS-SALVADó J，et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts［J］. N Engl J Med，2018，378（25）：e34. DOI：10.1056/nejmoa1800389.
［42］AZADBAKHT L，FARD N R，KARIMI M，et al. Effects of the Dietary Approaches to Stop Hypertension（DASH） eating plan on cardiovascular risks among type 2 diabetic patients：a randomized crossover clinical trial［J］. Diabetes Care，2011，34（1）：55-57. DOI：10.2337/dc10-0676.
［43］TANGESTANI H，SALARI-MOGHADDAM A，GHALANDARI H，et al. Adherence to the Dietary Approaches to Stop Hypertension（DASH） dietary pattern reduces the risk of colorectal cancer：a systematic review and meta-analysis［J］. Clin Nutr，2020，39（10）：2975-2981. DOI：10.1016/j.clnu.2020.02.002.
［44］CHRIST A，GüNTHER P，LAUTERBACH M A R，et al. Western diet triggers NLRP3-dependent innate immune reprogramming［J］. Cell，2018，172（1/2）：162-175.e14. DOI：10.1016/j.cell.2017.12.013.
［45］SAMIR P，MALIREDDI R K S，KANNEGANTI T D. Food for training-western diet and inflammatory memory［J］. Cell Metab，2018，27（3）：481-482. DOI：10.1016/j.cmet.2018.02.012.
［46］HAYASHI T，FUJITA K，NOJIMA S，et al. High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling［J］. Clin Cancer Res，2018，24（17）：4309-4318. DOI：10.1158/1078-0432.CCR-18-0106.
［47］ROAGER H M，VOGT J K，KRISTENSEN M，et al. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome：a andomized cross-over trial［J］. Gut，2019，68（1）：83-93. DOI：10.1136/gutjnl-2017-314786.
［48］MOZAFFARIAN D. Dietary and policy priorities for cardiovascular disease，diabetes，and obesity：a comprehensive review［J］. Circulation，2016，133（2）：187-225. DOI：10.1161/CIRCULATIONAHA.115.018585.
［49］REDMAN L M，SMITH S R，BURTON J H，et al. Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging［J］. Cell Metab，2018，27（4）：805-815.e4. DOI：10.1016/j.cmet.2018.02.019.
［50］FONTANA L，PARTRIDGE L，LONGO V D. Extending healthy life span——from yeast to humans［J］. Science，2010，328（5976）：321-326. DOI：10.1126/science.1172539.
［51］PICARD M，WALLACE D C，BURELLE Y.The rise of mitochondria in medicine［J］. Mitochondrion，2016，30：105-116. DOI：10.1016/j.mito.2016.07.003.
［52］LEE C，ZENG J，DREW B G，et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance［J］. Cell Metab，2015，21（3）：443-454. DOI：10.1016/j.cmet. 2015.02.009.
［53］TUMURKHUU G，SHIMADA K，DAGVADORJ J，et al. Ogg1-dependent DNA repair regulates NLRP3 inflammasome and prevents atherosclerosis［J］. Circ Res，2016，119（6）：e76-90. DOI：10.1161/CIRCRESAHA.116.308362.
［54］ARON-WISNEWSKY J，CLéMENT K.The gut microbiome，diet，and links to cardiometabolic and chronic disorders［J］. Nat Rev Nephrol，2016，12（3）：169-181. DOI：10.1038/nrneph.2015.191.
［55］GENTILE C L，WEIR T L. The gut microbiota at the intersection of diet and human health［J］. Science，2018，362（6416）：776-780. DOI：10.1126/science.aau5812.
［56］XIE Y D，ZHAO Y F，SHI L，et al. Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer［J］. J Clin Invest，2020，130（4）：2111-2128. DOI：10.1172/JCI133264.
［57］CATRY E，BINDELS L B，TAILLEUX A，et al. Targeting the gut microbiota with inulin-type fructans：preclinical demonstration of a novel approach in the management of endothelial dysfunction［J］. Gut，2018，67（2）：271-283. DOI：10.1136/gutjnl-2016-313316.
［58］AROKIASAMY P，UTTAMACHARYA U，JAIN K，et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries：what does the study on global ageing and adult health （SAGE） reveal？［J］. BMC Med，2015，13：178. DOI：10.1186/s12916-015-0402-8.
［59］YAMANASHI H，NOBUSUE K，NONAKA F，et al. The role of mental disease on the association between multimorbidity and medical expenditure［J］. Fam Pract，2020，37（4）：453-458. DOI：10.1093/fampra/cmaa015.
［60］SCHULZE T，MAERCKER A，HORN A B. Mental health and multimorbidity：psychosocial adjustment as an important process for quality of life［J］. Gerontology，2014，60（3）：249-254. DOI：10.1159/000358559.
［61］VOS R，AARTS S，VAN MULLIGEN E，et al. Finding potentially new multimorbidity patterns of psychiatric and somatic diseases：exploring the use of literature-based discovery in primary care research［J］. J Am Med Inform Assoc，2014，21（1）：139-145. DOI：10.1136/amiajnl-2012-001448.
［62］THOMA M V，GIANFERANTE D，HANLIN L K，et al. Stronger hypothalamus-pituitary-adrenal axis habituation predicts lesser sensitization of inflammatory response to repeated acute stress exposures in healthy young adults［J］. Brain Behav Immun，2017，61：228-235. DOI：10.1016/j.bbi.2016.11.030.
［48］VIGNES S，ARRAULT M，DUPUY A. Factors associated with increased breast cancer-related lymphedema volume［J］. Acta Oncol，2007，46（8）：1138-1142. DOI：10.1080/02841860701403020.
［49］LACOMBE J，MANGé A，BOUGNOUX A C，et al. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women［J］. Cancer Epidemiol Biomarkers Prev，2014，23（9）：1834-1842. DOI：10.1158/1055-9965.EPI-14-0267.
［50］陈怡安，贾红燕，张萌萌，等. 35岁以下三阴性乳腺癌临床病理特征及预后分析［J］. 海南医学，2019，30（13）：1657-1663. DOI：10.3969/j.issn.1003-6350.2019.13.006.
CHEN Y A，JIA H Y，ZHANG M M，et al. Clinicopathological features and prognosis of very young women（<35 years）with triple-negative breast cancer［J］. Hainan Medical Journal，2019，30（13）：1657-1663. DOI：10.3969/j.issn.1003-6350.2019.13.006.
［51］MICHELOTTI A，INVERNIZZI M，LOPEZ G，et al. Tackling the diversity of breast cancer related lymphedema：perspectives on diagnosis，risk assessment，and clinical management［J］. Breast，2019，44：15-23. DOI：10.1016/j.breast.2018.12.009.
［52］WEYCKER D，CHANDLER D，BARRON R，et al. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice［J］. J Oncol Pharm Pract，2017，23（1）：33-42. DOI：10.1177/1078155215614997.
［53］范威，吴新红. 乳腺癌新辅助化疗后手术时机的选择［J］. 临床外科杂志，2019，27（3）：183-186. DOI：10.3969/j.issn.1005-6483.2019.03.002. https://d.wanfangdata.com.cn/periodical/lcwkzz201903002．
［54］蔡耿喜，蔡子杰，陈前军，等. 乳腺癌新辅助化疗的现状与进展——南方乳腺癌论坛主要议题与共识［J］. 中国普通外科杂志，2019，28（11）：1309-1321. DOI：10.7659/j.issn.1005-6947.2019.11.001.
［63］MASON A E，SCHLEICHER S，COCCIA M，et al. Chronic stress and impulsive risk-taking predict increases in visceral fat over 18 months［J］. Obesity（Silver Spring），2018，26（5）：869-876. DOI：10.1002/oby.22150.
［64］NUSSLOCK R，MILLER G E. Early-life adversity and physical and emotional health across the lifespan：a neuroimmune network hypothesis［J］. Biol Psychiatry，2016，80（1）：23-32. DOI：10.1016/j.biopsych.2015. 05.017.
［65］GAULIN M，SIMARD M，CANDAS B，et al. Combined impacts of multimorbidity and mental disorders on frequent emergency department visits：a retrospective cohort study in Quebec，Canada［J］. CMAJ，2019，191（26）：E724-732. DOI：10.1503/cmaj.181712.
［66］COVENTRY P，LOVELL K，DICKENS C，et al. Integrated primary care for patients with mental and physical multimorbidity：cluster andomized controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease［J］. BMJ，2015，350：h638. DOI：10.1136/bmj.h638.
［67］BODENHEIMER T，LORIG K，HOLMAN H，et al. Patient self-management of chronic disease in primary care［J］. JAMA，2002，288（19）：2469-2475. DOI：10.1001/jama.288.19.2469.
［68］ABOUMATAR H，NAQIBUDDIN M，CHUNG S，et al. Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease：a randomized clinical trial［J］. JAMA，2019，322（14）：1371-1380. DOI：10.1001/jama.2019.11982.
［69］PETERS M，POTTER C M，KELLY L，et al. Self-efficacy and health-related quality of life：a cross-sectional study of primary care patients with multi-morbidity［J］. Health Qual Life Outcomes，2019，17（1）：37. DOI：10.1186/s12955-019-1103-3.
［70］YOUNG L A，BUSE J B，WEAVER M A，et al. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings：a randomized trial［J］. JAMA Intern Med，2017，177（7）：920-929. DOI：10.1001/jamainternmed.2017.1233.
［71］LUM E，JIMENEZ G，HUANG Z L，et al. Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes［J］. JAMA，2019，321（15）：1530-1532. DOI：10.1001/jama.2019.1644.
［72］HELGESON V S，JAKUBIAK B，VAN VLEET M，et al. Communal coping and adjustment to chronic illness：theory update and evidence［J］. Pers Soc Psychol Rev，2018，22（2）：170-195. DOI：10.1177/1088868317735767.
［73］OCHOA-AVILéS A，VERSTRAETEN R，HUYBREGTS L，et al. A school-based intervention improved dietary intake outcomes and reduced waist circumference in adolescents：a cluster randomized controlled trial［J］. Nutr J，2017，16（1）：79. DOI：10.1186/s12937-017-0299-5.
［74］DOWNER S，BERKOWITZ S A，HARLAN T S，et al. Food is medicine：actions to integrate food and nutrition into healthcare［J］. BMJ，2020，369：m2482. DOI：10.1136/bmj.m2482.
［75］ABRAHA I，CRUZ-JENTOFT A，SOIZA R L，et al. Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions：the SENATOR-ONTOP systematic review protocol［J］. BMJ Open，2015，5（1）：e007488. DOI：10.1136/bmjopen-2014-007488.

[1]	徐百川, 王艳, 张彭, 李艺婷, 刘飞来, 谢洋. 慢性阻塞性肺疾病共病肺癌筛查工具分析[J]. 中国全科医学, 2025, 28(30): 3847-3852.
[2]	扶蓉, 石磊, 何飞英. 中老年人糖尿病与抑郁状态共病：睡眠和运动及社交活动的影响研究[J]. 中国全科医学, 2025, 28(20): 2491-2500.
[3]	韩正, 孙梦, 傅方琳, 潘姚佳, 王为强. 50岁及以上人群三酰甘油葡萄糖指数与心血管代谢性共病关系的研究[J]. 中国全科医学, 2025, 28(18): 2278-2284.
[4]	黄志杰, 麦志华, 王皓翔, 何煜明, 邓巧妍, 戴燃然, 周志衡. 老年"三高"共患情况和家庭功能的现状及影响因素研究[J]. 中国全科医学, 2025, 28(16): 2001-2010.
[5]	宋明莎, 王宥匀, 李春生, 乔慧. 基于潜在类别分析的宁夏回族自治区南部山区农村老年人慢性病共病对日常生活活动能力的影响研究[J]. 中国全科医学, 2025, 28(16): 2033-2038.
[6]	曹晨晨, 郑吕云, 王琳, 刘静. 高血压与2型糖尿病共病患者家庭医生签约服务偏好研究[J]. 中国全科医学, 2025, 28(16): 2011-2016.
[7]	朱先尚, 曾泓钰, 吕凤丽, 王建成. 甘肃省60岁及以上老年人慢性病共病现状及影响因素研究[J]. 中国全科医学, 2025, 28(10): 1193-1199.
[8]	裴金英, 宋金洲, 马到丰, 罗孝廷, 刘斌, 董晓红, 丛树园. 中药提取物调控铁死亡改善阿尔茨海默病的研究新进展[J]. 中国全科医学, 2025, 28(05): 639-648.
[9]	信博, 吴艺新, 张迪, 何雨欣, 杨珊, 李梦驰, 蒋文慧. 慢性病共病患者认知功能障碍的研究进展[J]. 中国全科医学, 2025, 28(02): 143-148.
[10]	李小凤, 裴星童, 杨春晖, 赵洋, 徐明明. 老年人群慢性病共病模式与失能状况的关联研究：基于四川省抽样调查[J]. 中国全科医学, 2025, 28(02): 149-158.
[11]	李丽萍, 廖婧, 高鑫源, 王力, 赖颖斯. 中国共病加权指数与老年人卫生服务利用的关联性研究[J]. 中国全科医学, 2025, 28(01): 65-70.
[12]	罗原, 徐志杰, 夏瑀, 石佳娜, 蒋志志, 周馨媚, 赵洋, 童钰铃. 共病药物治疗决策——全科医生接诊病案研究[J]. 中国全科医学, 2025, 28(01): 119-124.
[13]	周馨媚, 韩利艳, 夏瑀, 李海昕, 罗原, 钱熠, 赵洋, 徐志杰. 社区全科医生慢性病共病药物治疗决策能力提升培训需求的定性研究[J]. 中国全科医学, 2025, 28(01): 111-118.
[14]	夏瑀, 罗原, 李峥嵘, 周馨媚, 童钰铃, 赵洋, 徐志杰. 社区慢性病共病药物治疗决策的困境与应对路径[J]. 中国全科医学, 2025, 28(01): 103-110.
[15]	苏比努尔·艾外都力, 古丽巴哈尔·卡德尔, 木开达斯·塔西, 吕宇娟, 卡迪尔亚·那斯尔, 苏比德·阿力木江. 农村地区中老年人群慢性病患病及共病模式对SRH状况的影响研究[J]. 中国全科医学, 2024, 27(28): 3520-3528.